Literature DB >> 23087268

Uterine adenosarcoma in a patient with history of breast cancer and long-term tamoxifen consumption.

Ali Akhavan1, Mahmood Akhavan Tafti, Farhad Aghili, Hossein Navabii.   

Abstract

Adenosarcoma is a rare tumour which usually originates from endometrium. This paper presents a 69-year-old woman with adenosarcoma of uterus and a history of breast cancer and 10 years tamoxifen therapy.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23087268      PMCID： PMC4543714          DOI： 10.1136/bcr-2012-006590

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN： 1757-790X


  13 in total

1.  Müllerian adenosarcoma of the uterus in association with tamoxifen therapy.

Authors:  F A Jessop; P F Roberts
Journal:  Histopathology       Date:  2000-01       Impact factor: 5.087

2.  PCR display identifies tamoxifen induction of the novel angiogenic factor adrenomedullin by a non estrogenic mechanism in the human endometrium.

Authors:  Y Zhao; S Hague; S Manek; L Zhang; R Bicknell; M C Rees
Journal:  Oncogene       Date:  1998-01-22       Impact factor: 9.867

3.  Mullerian adenosarcoma of the uterus associated with tamoxifen therapy.

Authors:  D S Arici; H Aker; E Yildiz; A Tasyurt
Journal:  Arch Gynecol Obstet       Date:  2000-09       Impact factor: 2.344

4.  Mullerian adenosarcoma of the uterus: a clinicopathologic analysis of 100 cases with a review of the literature.

Authors:  P B Clement; R E Scully
Journal:  Hum Pathol       Date:  1990-04       Impact factor: 3.466

5.  Müllerian adenosarcoma of the uterus with sarcomatous overgrowth following tamoxifen treatment for breast cancer.

Authors:  F M Carvalho; J P Carvalho; E V Motta; J Souen
Journal:  Rev Hosp Clin Fac Med Sao Paulo       Date:  2000 Jan-Feb

Review 6.  Tamoxifen and malignant epithelial-nonepithelial tumours of the endometrium: report of six cases and review of the literature.

Authors:  T Treilleux; H Mignotte; C Clement-Chassagne; P Guastalla; C Bailly
Journal:  Eur J Surg Oncol       Date:  1999-10       Impact factor: 4.424

7.  Pathology of endometrium treated with tamoxifen.

Authors:  S M Ismail
Journal:  J Clin Pathol       Date:  1994-09       Impact factor: 3.411

Review 8.  The effects of tamoxifen on the female genital tract.

Authors:  Elzbieta Senkus-Konefka; Tomasz Konefka; Jacek Jassem
Journal:  Cancer Treat Rev       Date:  2004-05       Impact factor: 12.111

9.  Uterine mullerian adenosarcoma following adenomyoma in a woman on tamoxifen therapy.

Authors:  T Bocklage; K R Lee; J L Belinson
Journal:  Gynecol Oncol       Date:  1992-01       Impact factor: 5.482

10.  Risk of malignant mixed mullerian tumors after tamoxifen therapy for breast cancer.

Authors:  Rochelle E Curtis; D Michal Freedman; Mark E Sherman; Joseph F Fraumeni
Journal:  J Natl Cancer Inst       Date:  2004-01-07       Impact factor: 13.506
View more
  4 in total

1.  Malignant mixed Mullerian tumour of uterus secondary to tamoxifen therapy for hormone responsive breast cancer.

Authors:  Mayank Gupta; Kala Gnanasekaran Kiruthiga
Journal:  BMJ Case Rep       Date:  2015-06-29

Review 2.  Uterine Adenosarcoma: a Review.

Authors:  Michael J Nathenson; Vinod Ravi; Nicole Fleming; Wei-Lien Wang; Anthony Conley
Journal:  Curr Oncol Rep       Date:  2016-11       Impact factor: 5.075

3.  A Single-Centre Experience on the Management of Adenosarcoma: A Successful Report of an Integrated Medical and Surgical Approach.

Authors:  Myriam Anna Perrone; Margherita Nannini; Giulia Dondi; Donatella Santini; Antonio De Leo; Angelo Paolo Dei Tos; Claudio Zamagni; Maristella Saponara; Lidia Gatto; Concetta Nigro; Paola Bertaccini; Maurizio Zompatori; Pierandrea De Iaco; Anna Myriam Perrone; Maria Abbondanza Pantaleo
Journal:  Clin Med Insights Oncol       Date:  2018-06-18

4.  Malignant Mixed Mullerian Tumor Secondary to Tamoxifen for Ca Breast: Shadow of the Past!

Authors:  Surendra Bisu; Vinu Choudhary
Journal:  J Midlife Health       Date:  2018 Oct-Dec
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.